LncRNA H19 promotes vascular remodeling by inhibiting MFN2
Authors:
- 14 September 2026
- journal article
- research article
- Published by Springer Nature in Functional & Integrative Genomics
- Vol. 26 (1) , 263
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Beijing (7242013)
- Shaanxi Province Postdoctoral Science Foundation (2023BSHGZZHQYXMZZ02)
This publication has 40 references indexed in Scilit:
- A review of molecular interplay between inflammation and cancer: The role of lncRNAs in pathogenesis and therapeutic potentialInternational Journal of Biological Macromolecules, 2025
- The role of long non-coding RNAs in cardiovascular diseases: A comprehensive reviewNon-coding RNA Research, 2025
- Hsa_circ_0001402 alleviates vascular neointimal hyperplasia through a miR-183-5p-dependent regulation of vascular smooth muscle cell proliferation, migration, and autophagyJournal of Advanced Research, 2023
- CircHIPK3 Regulates Vascular Smooth Muscle Cell Calcification Via the miR-106a-5p/MFN2 AxisJournal of Cardiovascular Translational Research, 2022
- Upregulation of miR‐675‐5p induced by lncRNA H19 was associated with tumor progression and development by targeting tumor suppressor p53 in non–small cell lung cancerJournal of Cellular Biochemistry, 2019
- Long noncoding RNA H19-derived miR-675 aggravates restenosis by targeting PTENBiochemical and Biophysical Research Communications, 2018
- MicroRNA-675 promotes glioma cell proliferation and motility by negatively regulating retinoblastoma 1Human Pathology, 2017
- miRNAs and lncRNAs in vascular injury and remodelingScience China Life Sciences, 2014
- Nifedipine inhibits vascular smooth muscle cell proliferation and reactive oxygen species production through AMP-activated protein kinase signaling pathwayVascular Pharmacology, 2012
- ROCK inhibition prevents fetal serum-induced alteration in structure and function of organ-cultured mesenteric arteryJournal of Muscle Research and Cell Motility, 2011